Abstract
Interstitial fibrosis of the lung is a final pathway of different lung disorders like idiopathic pulmonary fibrosis (IPF) or granulomatous lung diseases (for example sarcoidosis). Fibrotic areas were also found in patients suffering from chronic obstructive pulmonary disease (COPD). Acute lung injury (ALI) which can progress to acute respiratory distress syndrome (ARDS) can result in fibrotic tissue remodelling. Furthermore, during the course of asthma remodelling can lead to fibrosis as well.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, J.T. and Spiteri, M.A., 2002, Growth factors in idiopathic pulmonary fibrosis: relative roles. Respir. Res. 3: 13.
Antoniades, H.N., Bravo, M.A., Avila, R.E., Galanopoulos, T., Neville-Golden, J., Maxwell, M., and Selman, M., 1990, Platelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest 86: 1055–1064.
Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., et al., 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315–324.
Aston, C., Jagirdar, J., Lee, T.C., Hur, T., Hintz, R.L., and Rom, W.N., 1995, Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am. J. Respir. Crit Care Med. 151: 1597–1603.
Bachofen, M. and Weibel, E.R., 1982, Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3: 35–56.
Bienkowski, R.S. and Gotkin, M.G., 1995, Control of collagen deposition in mammalian lung. Proc. Soc. Exp. Biol. Med. 209: 118–140.
Blobel, C.P., 2000, Remarkable roles of proteolysis on and beyond the cell surface. Curr. Opin. Cell Biol. 12: 606–612.
Broekelmann, T.J., Limper, A.H., Colby, T.V., and McDonald, J.A., 1991, Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. U.S.A 88: 6642–6646.
Bühling, F., Reisenauer, A., Gerber, A., Krüger, S., Weber, E., Brömme, D., Roessner, A., Ansorge, S., Weite, T., and Röcken, C., 2001, Cathepsin K-a marker of macrophage differentiation? J. Pathol. 195: 375–382.
Carney, D.E., Lutz, C.J., Picone, A.L., Gatto, L.A., Ramamurthy, N.S., Golub, L.M., Simon, S.R., Searles, B., Paskanik, A., Snyder, K., Finck, C., Schiller, H.J., and Nieman, G.F., 1999, Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 100: 400–406.
Chapman, H.A., Allen, C.L., and Stone, O.L., 1986, Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis. 133: 437–443.
Chapman, H.A., Riese, R.J., and Shi, G.P., 1997, Emerging roles for cysteine proteases in human biology. Ann. Rev. Physiol. 59: 63–88.
Chua, C.C. and Chua, B.H., 1990, Tumor necrosis factor-alpha induces mRNA for collagenase and TIMP in human skin fibroblasts. Connect. Tissue Res. 25: 161–170.
Coker, R.K., Laurent, G.J., Shahzeidi, S., Lympany, P.A., du Bois, R.M., Jeffery, P.K., and McAnulty, R.J., 1997, Transforming growth factors-beta 1,-beta 2, and-beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 150: 981–991.
Corbel, M., Boichot, E., and Lagente, V., 2000, Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz. J.Med.Biol.Res. 33: 749–754.
Corbel, M., Caulet-Maugendre, S., Germain, N., Molet, S., Lagente, V., and Boichot, E., 2001, Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J. Pathol. 193: 538–545.
Corbel, M., Lagente, V., Theret, N., Germain, N., Clement, B., and Boichot, E., 1999, Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. Pulm. Pharmacol. Ther. 12: 165–171.
Corcoran, M.L. and Stetler-Stevenson, W.G., 1995, Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J. Biol. Chem. 270: 13453–13459.
Coussens, L.M., Shapiro, S.D., Soloway, P.D., and Werb, Z., 2001, Models for gain-of-function and loss-of-function of MMPs. Transgenic and gene targeted mice. Methods Mol. Biol. 151: 149–179.
Crawford, S.E., Stellmach, V., Murphy-Ullrich, J.E., Ribeiro, S.M., Lawler, J., Hynes, R.O., Boivin, G.P., and Bouck, N., 1998, Thrombospondin-1 is a major activator of TGF-betal in vivo. Cell 93: 1159–1170.
Crouch, E., 1990, Pathobiology of pulmonary fibrosis. Am.J.Physiol 259: L159–L184.
D’Armiento, J., Dalai, S.S., Okada, Y., Berg, R.A., and Chada, K., 1992, Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71: 955–961.
Davidson, J.M., 1990, Biochemistry and turnover of lung interstitium. Eur. Respir. J. 3: 1048–1063.
Diaz, A., Willis, A.C., and Sim, R.B., 2000, Expression of the proteinase specialized in bone resorption, cathepsin K., in granulomatous inflammation. Mol. Med. 6: 648–659.
Eickelberg, O., Kohler, E., Reichenberger, F., Bertschin, S., Woodtli, T., Erne, P., Perruchoud, A.P., and Roth, M., 1999, Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-betal and TGF-beta3. Am. J. Physiol 276: L814–L824.
Everts, V., van der Zee, E., Creemers, L., and Beertsen, W., 1996, Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem. J. 28: 229–245.
Ferry, G., Lonchampt, M., Pennel, L., de Nanteuil, G., Canet, E., and Tucker, G.C., 1997, Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett. 402: 111–115.
Fowlkes, J.L., Enghild, J.J., Suzuki, K., and Nagase, H., 1994a, Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269: 25742–25746.
Fowlkes, J.L., Suzuki, K., Nagase, H., and Thrailkill, K.M., 1994b, Proteolysis of insulinlike growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. Endocrinol. 135: 2810–2813.
Fowlkes, J.L. and Winkler, M.K., 2002, Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability. Cytokine Growth Factor Rev. 13: 277–287.
Fukuda, Y., Ishizaki, M., Kudoh, S., Kitaichi, M., and Yamanaka, N., 1998, Localization of matrix metalloproteinases-l,-2, and-9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab. Invest. 78: 687–698.
Fukuda, Y., Ishizaki, M., Masuda, Y., Kimura, G., Kawanami, O., and Masugi, Y., 1987, The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126: 171–182.
Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F.H., McQueney, M., Foged, N.T., Delmas, P.D., and Delaissé, J.M., 1998, The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273: 32347–32352.
Haro, H., Crawford, H.C., Fingleton, B., Shinomiya, K., Spengler, D.M., and Matrisian, L.M., 2000, Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc rsorption. J. Clin. Invest. 105: 143–150.
Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., and Shapiro, S.D., 1997, Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002–2004.
Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., and Iwata, K., 1992, Growth-promoting activity of tissue inhibitor of metalloproteinases-l (TIMP-1) for a wide range of cells. A possible new growth factor in serum.FEBS Lett. 298: 29–32.
Hayashi, T., Stetler-Stevenson, W.G., Fleming, M.V., Fishback, N., Koss, M.N., Liotta, L.A., Ferrans, V.J., and Travis, W.D., 1996, Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am. J. Pathol. 149: 1241–1256.
Holgate, S.T., Lackie, P.M., Davies, D.E., Roche, W.R., and Walls, A.F., 1999, The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin. Exp. Allergy 29 Suppl 2: 90–95.
Hou, W.S., Li, Z., Gordon, R.E., Chan, K., Klein, M.J., Levy, R., Keysser, M., Keyszer, G., and Bromme, D., 2001, Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am. J. Pathol. 159: 2167–2177.
Infeld, M.D., 1997, Cell-matrix interactions in gland development in the lung. Exp. Lung Res. 23: 161–169.
Ito, A., Sato, T., Iga, T., and Mori, Y., 1990, Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett. 269: 93–95.
Jagirdar, J., Begin, R., Dufresne, A., Goswami, S., Lee, T.C., and Rom, W.N., 1996, Transforming growth factor-beta (TGF-beta) in silicosis. Am. J. Respir. Crit. Care Med. 154: 1076–1081.
Kelly, E.A., Busse, W.W., and Jarjour, N.N., 2000, Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am. J. Respir. Crit. Care Med. 162: 1157–1161.
Lardot, C., Delos, M., and Lison, D., 1998a, Upregulation of urokinase in alveolar macrophages and lung tissue in response to silica particles. Am. J. Physiol 274: L1040–L1048.
Lardot, C., Heusterpreute, M., Mertens, P., Philippe, M., and Lison, D., 1998b, Expression of plasminogen activator inhibitors type-1 and type-2 in the mouse lung after administration of crystalline silica. Eur. Respir. J. 11: 912–921.
Lasky, J.A. and Brody, A.R., 2000, Interstitial fibrosis and growth factors. Environ. Health Perspect. 108 Suppl 4: 751–762.
Lemjabbar, H., Gesset, P., Lechapt-Zalcman, E., Franco-Montoya, M.L., Wallaert, B., Harf, A., and Lafuma, C., 1999, Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am. J. Respir. Cell Mol. Biol. 20: 903–913.
Locksley, R.M., Killeen, N., and Lenardo, M.J., 2001, The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487–501.
Lyons, R.M., Gentry, L.E., Purchio, A.F., and Moses, H.L., 1990, Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 110: 1361–1367.
Mariani, T.J., Roby, J.D., Mecham, R.P., Parks, W.C., Crouch, E., and Pierce, R.A., 1996, Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-beta as a mediator of fibrosis. Am. J. Pathol. 148: 151–164.
Martin, C., Papazian, L., Payan, M.J., Saux, P., and Gouin, F., 1995, Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 107: 196–200.
Munger, J.S., Huang, X., Kawakatsu, H., Griffiths, M.J., Dalton, S.L., Wu, J., Pittet, J.F., Kaminski, N., Garat, C., Matthay, M.A., Rifkin, D.B., and Sheppard, D., 1999, The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319–328.
Nagase, H. and Woessner, J.F., Jr., 1999, Matrix metalloproteinases. J. Biol. Chem. 274: 21491–21494.
Nogee, L.M., Dunbar, A.E., III, Wert, S.E., Askin, F., Hamvas, A., and Whitsett, J.A., 2001, A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344: 573–579.
Overall, C.M., Wrana, J.L., and Sodek, J., 1989, Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J. Biol. Chem. 264: 1860–1869.
Parks, W.C., Lopez-Boado, Y.S., and Wilson, C.L., 2001a, Matrilysin in epithelial repair and defense. Chest 120: 36S–41S.
Parks, W.C. and Shapiro, S.D., 2001b, Matrix metalloproteinases in lung biology. Respir. Res. 2: 10–19.
Perez-Ramos, J., Lourdes Segura-Valdez, M., Vanda, B., Selman, M., and Pardo, A., 1999, Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am. J. Respir. Crit. Care Med. 160: 1274–1282.
Piguet, P.F., Collart, M.A., Grau, G.E., Sappino, A.P., and Vassalli, P., 1990, Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344: 245–247.
Raghu, G., Johnson, W.C, Lockhart, D., and Mageto, Y., 1999, Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am. J. Respir. Crit. Care Med. 159: 1061–1069.
Raghu, G., Striker, L.J., Hudson, L.D., and Striker, G.E., 1985, Extracellular matrix in normal and fibrotic human lungs. Am. Rev. Respir. Dis. 131: 281–289.
Ramos, C., Montano, M., Garcia-Alvarez, J., Ruiz, V., Uhal, B.D., Selman, M., and Pardo, A., 2001, Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am. J. Respir. Cell Mol. Biol. 24: 591–598.
Ramos, C., Montano, M., Gonzalez, G., Vadillo, F., and Selman, M., 1988, Collagen metabolism in experimental lung silicosis. A trimodal behavior of collagenolysis. Lung 166: 347–353.
Reddy, V.Y., Zhang, Q.Y., and Weiss, S.J., 1995, Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. U.S.A. 92: 3849–3853.
Röcken, C., Stix, B., Brömme, D., Ansorge, S., Roessner, A., and Bühling, F., 2001, A putative role for cathepsin K in degradation of AA and AL amyloidosis. Am. J. Pathol. 158: 1029–1038.
Selman, M., King, T.E., and Pardo, A., 2001, Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134: 136–151.
Selman, M., Montano, M., Ramos, C., and Chapela, R., 1986, Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax 41: 355–359.
Shapiro, S.D., 1999, Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb. Haemost. 82: 846–849.
Shapiro, S.D., 2000, Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease. Clin. Chest Med. 21: 621–632.
Shapiro, S.D. and Senior, R.M., 1999, Matrix metalloproteinases. Matrix degradation and more. Am. J. Respir. Cell Mol. Biol. 20: 100–1102.
Shi, G.P., Munger, J.S., Meara, J.P., Rich, D.H., and Chapman, H.A., 1992, Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267: 7258–7262.
Stamenkovic, I., 2000, Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol. 10:415–433.
Suga, M., lyonaga, K., Okamoto, T., Gushima, Y., Miyakawa, H., Akaike, T., and Ando, M., 2000, Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 162: 1949–1956.
Taipale, J. and Keski-Oja, J., 1997, Growth factors in the extracellular matrix. FASEB J. 11: 51–59.
Taipale, J., Saharinen, J., Hedman, K., and Keski-Oja, J., 1996, Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J. Histochem. Cytochem. 44: 875–889.
Tanaka, H., Miyazaki, N., Oashi, K., Tanaka, S., Ohmichi, M., and Abe, S., 2000, Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J. Allergy Clin. Immunol. 105: 900–905.
Ward, P.A. and Hunninghake, G.W., 1998, Lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 157: S123–S129.
Warner, R.L., Beltran, L., Younkin, E.M., Lewis, C.S., Weiss, S.J., Varani, J., and Johnson, K.J., 2001, Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am. J. Respir. Cell Mol. Biol. 24: 537–544.
Yu, Q. and Stamenkovic, I., 2000, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163–176.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wille, A., Welte, T., Bühling, F. (2003). Proteases in interstitial lung diseases. In: Lendeckel, U., Hooper, N.M. (eds) Proteases in Tissue Remodelling of Lung and Heart. Proteases in Biology and Disease, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9082-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9082-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4786-6
Online ISBN: 978-1-4419-9082-2
eBook Packages: Springer Book Archive